Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of pretreatment with ranitidine bismuth citrate on Helicobacter pylori eradication cure rates
KCT0005871Phase 4Terminated
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranitidine bismuth citrate in Helicobacter pylori infection, gastritis, sponsored by Daewoong Pharmaceutical. Started Jun 2019; status: terminated.
02
Drugs
ranitidine bismuth citrate
03
Conditions
Helicobacter pylori infectiongastritis
Beyond the preview
Go deeper on KCT0005871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005871.